These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Yanamandra N; Konduri SD; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Nicolson GL; Obeyeseke M; Rao JS Clin Exp Metastasis; 2000; 18(7):611-5. PubMed ID: 11688967 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. Adachi Y; Lakka SS; Chandrasekar N; Yanamandra N; Gondi CS; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Tamiya T; Ohmoto T; Kouraklis G; Aggarwal B; Rao JS J Biol Chem; 2001 Dec; 276(50):47171-7. PubMed ID: 11572856 [TBL] [Abstract][Full Text] [Related]
24. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187 [TBL] [Abstract][Full Text] [Related]
25. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Kondraganti S; Gondi CS; McCutcheon I; Dinh DH; Gujrati M; Rao JS; Olivero WC Int J Oncol; 2006 Jun; 28(6):1353-60. PubMed ID: 16685436 [TBL] [Abstract][Full Text] [Related]
26. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972 [TBL] [Abstract][Full Text] [Related]
27. Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Krishnamoorthy B; Darnay B; Aggarwal B; Dinh DH; Kouraklis G; Olivero WC; Gujrati M; Rao JS Clin Cancer Res; 2001 Dec; 7(12):4195-201. PubMed ID: 11751520 [TBL] [Abstract][Full Text] [Related]
28. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647 [TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells. Mohan PM; Lakka SS; Mohanam S; Kin Y; Sawaya R; Kyritsis AP; Nicolson GL; Rao JS Clin Exp Metastasis; 1999; 17(7):617-21. PubMed ID: 10845561 [TBL] [Abstract][Full Text] [Related]
34. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332 [TBL] [Abstract][Full Text] [Related]
36. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of tumor growth by β-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model. Shi H; Liu L; Liu LM; Geng J; Chen L Melanoma Res; 2015 Feb; 25(1):15-21. PubMed ID: 25405459 [TBL] [Abstract][Full Text] [Related]
38. β-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9. Shi H; Liu L; Liu L; Geng J; Zhou Y; Chen L Melanoma Res; 2014 Apr; 24(2):99-107. PubMed ID: 24535052 [TBL] [Abstract][Full Text] [Related]
39. A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas. Kin Y; Chintala SK; Go Y; Sawaya R; Mohanam S; Kyritsis AP; Rao JS Int J Oncol; 2000 Jul; 17(1):61-5. PubMed ID: 10853019 [TBL] [Abstract][Full Text] [Related]
40. RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells. Li C; Cao S; Liu Z; Ye X; Chen L; Meng S Int J Cancer; 2010 Oct; 127(7):1507-16. PubMed ID: 20063318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]